Selective serotonin reuptake inhibitor prescribing before, during and after pregnancy: a population‐based study in six European regions
Open Access
- 28 October 2014
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 122 (7) , 1010-1020
Abstract
Objective: To explore the prescribing patterns of selective serotonin reuptake inhibitors (SSRIs) before, during and after pregnancy in six European population‐based databases.Design: Descriptive drug utilisation study.Setting: Six electronic healthcare databases in Denmark, the Netherlands, Italy (Emilia Romagna/Tuscany), Wales and the rest of the UK.Population: All women with a pregnancy ending in a live or stillbirth starting and ending between 2004 and 2010.Methods: A common protocol was implemented across databases to identify SSRI prescriptions issued (UK) or dispensed (non‐UK) in the year before, during or in the year following pregnancy.Main outcome measures: The percentage of deliveries in which the woman received an SSRI prescription in the year before, during or in the year following pregnancy. We also compared the choice of SSRIs and changes in prescribing over the study period.Results: In total, 721 632 women and 862 943 deliveries were identified. In the year preceding pregnancy, the prevalence of SSRI prescribing was highest in Wales [9.6%; 95% confidence interval (CI95), 9.4–9.8%] and lowest in Emilia Romagna (3.3%; CI95, 3.2–3.4%). During pregnancy, SSRI prescribing had dropped to between 1.2% (CI95, 1.1–1.3%) in Emilia Romagna and 4.5% (CI95, 4.3–4.6%) in Wales. The higher UK pre‐pregnancy prescribing rates resulted in higher first trimester exposures. After pregnancy, SSRI prescribing increased most rapidly in the UK. Paroxetine was more commonly prescribed in the Netherlands and Italian regions than in Denmark and the UK.Conclusions: The higher SSRI prescribing rates in the UK, compared with other European regions, raise questions about differences in the prevalence and severity of depression and its management in pregnancy across Europe.Keywords
Funding Information
- European Commission (HEALTH-F5-2011-260598)
This publication has 42 references indexed in Scilit:
- Volunteer Bias in Recruitment, Retention, and Blood Sample Donation in a Randomised Controlled Trial Involving Mothers and Their Children at Six Months and Two Years: A Longitudinal AnalysisPLOS ONE, 2013
- Increasing the risk of spontaneous abortion and major malformations in newborns following use of serotonin reuptake inhibitors during pregnancy: A systematic review and updated meta-analysisDARU Journal of Pharmaceutical Sciences, 2012
- Primary Medication Non-Adherence: Analysis of 195,930 Electronic PrescriptionsJournal of General Internal Medicine, 2010
- The SAIL Databank: building a national architecture for e-health research and evaluationBMC Health Services Research, 2009
- Selective Serotonin Reuptake Inhibitor Use and Risk of Gestational HypertensionAmerican Journal of Psychiatry, 2009
- Initiation of antidepressant therapy: do patients follow the GP's prescription?British Journal of General Practice, 2009
- The SAIL databank: linking multiple health and social care datasetsBMC Medical Informatics and Decision Making, 2009
- Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population‐based cohort study from the NetherlandsBritish Journal of Clinical Pharmacology, 2007
- Prevalence and predictors of antidepressant use in a cohort of pregnant womenBJOG: An International Journal of Obstetrics & Gynaecology, 2007
- The General Practice Research DatabaseDrug Safety, 2004